Page last updated: 2024-12-06

1-octen-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-octen-3-one is an unsaturated ketone with a characteristic mushroom-like odor. It is found naturally in various sources, including mushrooms, truffles, coffee, and some fruits. It is synthesized through various methods, including the condensation of octanal with formaldehyde. 1-octen-3-one is known to have both attractive and repellent effects on insects, depending on the species and concentration. It is also reported to have antifungal and antibacterial activities. Research on 1-octen-3-one focuses on its potential as a natural food flavoring agent, as well as its potential applications in pest control and antimicrobial therapies. '

1-octen-3-one: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID61346
CHEMBL ID3186486
CHEBI ID88900
SCHEMBL ID84084
SCHEMBL ID6081600
MeSH IDM0293743

Synonyms (41)

Synonym
vinyl amyl ketone
1-octen-3-one
1-octen-3-one, 50 wt. % in 1-octen-3-ol, stabilized, fg
ai3-37821
einecs 224-327-5
fema no. 3515
amyl vinyl ketone
4312-99-6
oct-1-en-3-one
AKOS007930624
LMFA12000011
cas-4312-99-6
NCGC00256809-01
dtxcid3027162
dtxsid5047162 ,
tox21_302710
A826166
pentyl vinyl ketone
O0382
unii-7lt7z4q9xr
7lt7z4q9xr ,
FT-0608182
1-octen-3-one [fhfi]
n-pentyl vinyl ketone
SCHEMBL84084
SCHEMBL6081600
1-octene-3-one
chebi:88900 ,
CHEMBL3186486
mfcd00036558
1-octen-3-one, 96%
1-octen-3-one, analytical standard
n-amyl vinyl ketone
octen-3-one, 1
fema 3515
BBL103313
STL557123
DS-8605
Q5074300
D71008
?1-octen-3-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency25.35470.000714.592883.7951AID1259369
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.45)18.2507
2000's9 (31.03)29.6817
2010's11 (37.93)24.3611
2020's8 (27.59)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.80 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index5.51 (4.65)
Search Engine Demand Index57.00 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (93.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]